HTG Molecular Diagnostics Revenue and Competitors

Tucson, AZ USA

Location

$89M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • HTG Molecular Diagnostics's estimated annual revenue is currently $17.8M per year.(i)
  • HTG Molecular Diagnostics's estimated revenue per employee is $349,510
  • HTG Molecular Diagnostics's total funding is $89M.

Employee Data

  • HTG Molecular Diagnostics has 51 Employees.(i)
  • HTG Molecular Diagnostics grew their employee count by -39% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M620%N/AN/A
#3
$1.7M11-45%N/AN/A
#4
$5.3M340%N/AN/A
#5
$4M26-7%N/AN/A
#6
$2.5M16129%N/AN/A
#7
$1.4M9-25%N/AN/A
#8
$2.2M2921%$58.2MN/A
#9
$177M1142-6%N/AN/A
#10
$0.9M6200%N/AN/A
Add Company

HTG Molecular Diagnostics is a leading provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. The Company's qNPAT molecular technology platform is well-suited for reliably detecting small, yet important, changes in gene expression levels in a variety of sample types. Privately-held HTG is based in Tucson, Arizona. Additional information is available at www.htgmolecular.com

keywords:Biotechnology

$89M

Total Funding

51

Number of Employees

$17.8M

Revenue (est)

-39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

HTG Molecular Diagnostics News

2022-04-13 - What is the Market's View on HTG Molecular Diagnostics Inc (HTGM) Stock's Price and Volume Trends Monday?

HTG Molecular Diagnostics Inc is a commercial stage RNA platform-based life sciences company focused on advancing the promise of precision...

2022-03-30 - HTG Releases Proof-of-Approach Whitepaper Establishing ...

TUCSON, Ariz., March 31, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing...

2022-03-22 - HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2021 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2021 Results - Earnings Call Transcript. Mar. 29, 2022 9:29 PM ETHTG Molecular Diagnostics,...

2011-06-13 - HTG Molecular Diagnostics Receives $500k from SR One in Series D Financing

HTG Molecular Diagnostics, a Tucson, Arizona-based provider of molecular technology solutions, has received a $500k investment from SR One, the corporate venture capital arm of GlaxoSmithKline, in the second tranche of its series D financing (read the news). The company, which has raised $16.2m ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.3M51-26%N/A
#2
$9.4M519%N/A
#3
$12.4M51-4%N/A
#4
$7.5M514%N/A
#5
$12.6M5218%N/A